Clinical Trials Directory

Trials / Unknown

UnknownNCT06244693

SUbCONgestion in Heart Failure Registry

Description and Analysis of Congestion During Hospitalization for Acute Decompensated Heart Failure

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
University of Chile · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The goal of this observational study is to learn about the decongestion process in heart failure patients. The main question it aims to answer is: What is the behavior of congestion during hospitalization in adult patients with acute heart failure (AHF)? Participants will be evaluated in the decongestion process through clinical, analytical, and ultrasonographic variables, and they will be followed up for one year to assess mortality and rehospitalization rates in this population.

Detailed description

Heart failure (HF) is a syndrome characterized by the presence of dyspnea, lower extremity edema, orthopnea, jugular venous distention, and pulmonary crackles, among others, secondary to elevated ventricular filling pressures. It is the leading cause of hospitalization in medical services in Chile and worldwide, with the majority of patients being elderly. Decompensation of HF is explained in most cases by fluid overload (congestion) and can be studied through biomarkers, clinical signs, radiographic, and ultrasonographic findings. The Chilean demographic transition makes it necessary to optimize the multiparametric and protocolized management of hospitalized patients. General Objective: To evaluate and describe the decongestion process, including residual congestion, during hospitalization for heart failure at the Clinical Hospital of the University of Chile (HCUCh). A prospective observational cohort study will be conducted with all patients hospitalized for heart failure at HCUCh. Clinical, analytical, and ultrasonographic variables, especially those related to congestion assessment, will be recorded. Enrollment will last for one year from institutional authorization, and telephone follow-up will be conducted for one year post-discharge, extendable up to five year.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionNo intervention

Timeline

Start date
2024-04-01
Primary completion
2025-02-01
Completion
2026-02-01
First posted
2024-02-06
Last updated
2024-06-12

Locations

1 site across 1 country: Chile

Source: ClinicalTrials.gov record NCT06244693. Inclusion in this directory is not an endorsement.